1.Niederman, MS, Ahmed, QAA.Community-acquired pneumonia in elderly patients. Clinics in Geriatric Medicine 2003; 19: 101–120.
2.Loeb, M.Pneumonia in older persons. Clinical Infectious Diseases 2003; 37: 1335–1339.
3.Vila-Córcoles, A, et al. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects. European Respiratory Journal 2005; 26: 1086–1091.
4.Jokinen, C, et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. American Journal of Epidemiology 2003; 137: 977–988.
5.Wilson, PA, Ferguson, J. Severe community-acquired pneumonia: an Australian perspective. Internal Medicine Journal 2005; 35: 699–705.
6.Padiglione, AA, et al. Characteristics of patients with community-acquired pneumococcal pneumonia. Medical Journal of Australia 1999; 170: 165–167.
7.Thompson, JE.Community acquired pneumonia in north eastern Australia – a hospital based study of aboriginal and non-aboriginal patients. Australian & New Zealand Journal of Medicine 1997; 27: 59–61.
8.Lim, I, et al. A prospective hospital study of the aetiology of community-acquired pneumonia. Medical Journal of Australia 1989; 151: 87–91.
9.Wacholder, S.Practical considerations in choosing between the case-cohort and nested case-control designs. Epidemiology 1991; 2: 155–158.
10.Department of Human Services Victoria. Victorian Inpatient Minimum Dataset 1996–1999. Melbourne, 2004.
11.Smith, PR.What diagnostic tests are needed for community-acquired pneumonia? Medical Clinics of North America 2001; 85: 1381–1396.
12.Metlay, JP, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Archives of Internal Medicine 1997; 157: 1453–1459.
13.Neill, AM, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax 1996; 51: 1010–1016.
14.Intercooled Stata 9.1 for Windows. Version 9.1 [program]. College Station, TX: StataCorp LP, 2005.
15.Marston, BJ, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Archives of Internal Medicine 1997; 157: 1709–1718.
16.Tsirgiotis, E, Ruffin, R. Community acquired pneumonia. A perspective for general practice. Australian Family Physician 2000; 29: 639–645.
17.Kaplan, V, et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. American Journal of Respiratory and Critical Care Medicine 2002; 165: 766–772.
18.Riquelme, R, et al. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. American Journal of Respiratory and Critical Care Medicine 1996; 154: 1450–1455.
19.Conte, HA, et al. A prognostic rule for elderly patients admitted with community-acquired pneumonia. American Journal of Medicine 1999; 106: 20–28.
20.Koivula, I, Sten, M, Makela, PH. Risk factors for pneumonia in the elderly. American Journal of Medicine 1994; 96: 313–320.
21.Mortensen, EM, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Archives of Internal Medicine 2002; 162: 1059–1064.
22.Kaplan, V, et al. Pneumonia: still the old man's friend? [see comment]. Archives of Internal Medicine 2003; 163: 317–323.
23.Rivetti, D, et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004876.
24.Skull, SA, et al. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated. Vaccine 2007; 25: 4631–4640.
25.Loeb, M. Epidemiology of community- and nursing home-acquired pneumonia in older adults. Expert Review of Antiinfective Therapy 2005; 3: 263–270.
26.Antibiotic Expert Group. Therapeutic Guidelines: Antibiotic, 11th edn.North Melbourne: Therapeutic Guidelines Limited, 2000.
27.Skull, SA, et al. ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged ⩾65 years. Epidemiology and Infection 2008; 136: 232–240.
28.Andrews, RM. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Vaccine 2005; 23: 2756–2761.